News Novartis taking aim at Pfizer with new use for breast cancer... FDA grants Breakthrough Therapy for Kisqali in premenopausal women.
News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
News Merck and Pfizer’s immunotherapy combination gains Breakthro... Merck and Pfizer have received a major boost to their immune-oncology alliance with a second FDA Breakthrough Therapy Designation for Bavencio, this time in combination with Pfizer’s Inlyta
News Janssen jumps into CAR-T field with China’s Legend Biotech J&J has struck a deal with Chinese biotech company Genscript, giving it entry to the global market for CAR-T therapies.
News Roche pays $1.7 billion for cancer specialist Ignyta Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta.
News Takeda interested in next-generation immuno-oncology deals Japanese firm wants to build presence in cancer
News Obesity needs a new clinical definition, study finds The current definition of obesity based on BMI isn't nuanced enough to gauge health and the need for weight-loss therapies, according to a new study.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
